Associations between non-coding RNAs genetic polymorphisms with ovarian cancer risk: A systematic review and meta-analysis update with trial sequential analysis

被引:3
作者
Liu, Huaying [1 ]
Sun, Lili [2 ]
Liu, Xiaoping [3 ]
Wang, Ruichai [3 ]
Luo, Qinqin [1 ]
机构
[1] Wuhan 1 Hosp, Dept Tradit Chinese Med, Wuhan 430022, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Gynaecol Oncol, Wuhan, Peoples R China
[3] Cent Hosp Xianning, Dept Geriatr, Xianning, Peoples R China
关键词
gene polymorphism; meta-analysis; non-coding RNAs; ovarian cancer risk; BREAST-CANCER; LUNG-CANCER; H19; GENE; SUSCEPTIBILITY; SNP; BINDING; PROGNOSIS; MODIFIERS; RS920778; MIR-146A;
D O I
10.1097/MD.0000000000035257
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This systemic review and meta-analysis seeks to systematically analyze and summarize the association between non-coding RNA polymorphisms and ovarian cancer risk.Methods: We searched PubMed, Web of Science and CNKI for available articles on non-coding RNA polymorphisms in patients with ovarian cancer from inception to March 1, 2023. The quality of each study included in the meta-analysis was rated according to the Newcastle-Ottawa Scale. Odds ratios (ORs) with their 95% confidence intervals (95% CI) were used to assess associations. Chi-square Q-test combined with inconsistency index (I2) was used to test for heterogeneity among studies. Lastly, trial sequential analysis (TSA) software was used to verify the reliability of meta-analysis results, and in-silico miRNA expression were also performed. The meta-analysis was registered with PROSPERO (No. CRD42023422091).Methods: We searched PubMed, Web of Science and CNKI for available articles on non-coding RNA polymorphisms in patients with ovarian cancer from inception to March 1, 2023. The quality of each study included in the meta-analysis was rated according to the Newcastle-Ottawa Scale. Odds ratios (ORs) with their 95% confidence intervals (95% CI) were used to assess associations. Chi-square Q-test combined with inconsistency index (I2) was used to test for heterogeneity among studies. Lastly, trial sequential analysis (TSA) software was used to verify the reliability of meta-analysis results, and in-silico miRNA expression were also performed. The meta-analysis was registered with PROSPERO (No. CRD42023422091).Results: A total of 17 case-control studies with 18 SNPs were selected, including 2 studies with H19 rs2107425 and HOTAIR rs4759314, and 5 studies with miR-146a rs2910164 and miR-196a rs11614913. Significant associations were found between H19 rs2107425, miR-146a rs2910164, and miR-196a rs11614913 and ovarian cancer risk. Three genetic models of H19 rs2107425 (CT vs TT (heterozygote model): OR = 1.36, 95% CI = 1.22-1.52, P < .00001; CC + CT vs TT (dominant model): OR = 1.12, 95% CI = 1.02-1.24, P = .02; and CC vs CT + TT (recessive model): OR = 1.23, 95% CI = 1.16-1.31, P < .00001), 2 genetic models of miR-146a rs2910164 (allele model: OR = 1.75, 95% CI = 1.05-2.91, P = .03; and heterozygote model: OR = 0.33, 95% CI = 0.11-0.98, P = .05), 3 genetic models of miR-196a rs11614913 (allele model: OR = 0.70, 95% CI = 0.59-0.82, P < .0001; dominant model: OR = 1.62, 95% CI = 1.18-2.24, P = .0001; and recessive model: OR = 0.70, 95% CI = 0.57-0.87, P = .03) were statistically linked to ovarian cancer risk. Subgroup analysis for miR-146a rs2910164 was performed according to ethnicity. No association was found in any genetic model. The outcomes of TSA also validated the findings of this meta-analysis.Conclusion: This study summarizes that H19 rs2107425, miR-146a rs2910164, and miR-196a rs11614913 polymorphisms are significantly linked with the risk of ovarian cancer, and moreover, large-scale and well-designed studies are needed to validate our result.
引用
收藏
页数:13
相关论文
共 53 条
[1]   Polymorphisms in DNA repair genes and epithelial ovarian cancer risk [J].
Auranen, A ;
Song, HL ;
Waterfall, C ;
DiCioccio, RA ;
Kuschel, B ;
Kjaer, SK ;
Hogdall, E ;
Hogdall, C ;
Stratton, J ;
Whittemore, AS ;
Easton, DF ;
Ponder, BAJ ;
Novik, KL ;
Dunning, AM ;
Gayther, S ;
Pharoah, PDP .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (04) :611-618
[2]   The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis [J].
Barsyte-Lovejoy, Dalia ;
Lau, Suzanne K. ;
Boutros, Paul C. ;
Khosravi, Fereshteh ;
Jurisica, Igor ;
Andrulis, Irene L. ;
Tsao, Ming S. ;
Penn, Linda Z. .
CANCER RESEARCH, 2006, 66 (10) :5330-5337
[3]   LNCcation: lncRNA localization and function [J].
Bridges, Mary Catherine ;
Daulagala, Amanda C. ;
Kourtidis, Antonis .
JOURNAL OF CELL BIOLOGY, 2021, 220 (02)
[4]   Rs145204276 and rs4759314 affect the prognosis of prostate cancer by modulating the GAS5/miR-1284/HMGB1 and HOTAIR/miR-22/HMGB1 signalling pathways [J].
Deng, Zhi-Hai ;
Yu, Gan-Shen ;
Pan, Bin ;
Feng, Zhen-Hua ;
Huang, Qiang ;
Deng, Jian-Zhong ;
Chen, Bo ;
Yang, Shi-Kun .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) :435-442
[5]   Using high-throughput SNP technologies to study cancer [J].
Engle, LJ ;
Simpson, CL ;
Landers, JE .
ONCOGENE, 2006, 25 (11) :1594-1601
[6]   Low penetrance alleles as risk modifiers in familial and sporadic breast cancer [J].
Esteban Cardenosa, Eva ;
de Juan Jimenez, Inmaculada ;
Palanca Suela, Sarai ;
Chirivella Gonzalez, Isabel ;
Segura Huerta, Angel ;
Santaballa Beltran, Ana ;
Casals El Busto, Maria ;
Barragan Gonzalez, Eva ;
Fuster Lluch, Oscar ;
Bermudez Edo, Jose ;
Bolufer Gilabert, Pascual .
FAMILIAL CANCER, 2012, 11 (04) :629-636
[7]   Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer [J].
Fang, Yiwen ;
Fullwood, Melissa J. .
GENOMICS PROTEOMICS & BIOINFORMATICS, 2016, 14 (01) :42-54
[8]   The rs2910164:G&gt;C SNP in the MIR146A Gene is Not Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers [J].
Garcia, Amandine I. ;
Cox, David G. ;
Barjhoux, Laure ;
Verny-Pierre, Carole ;
Barnes, Daniel ;
Antoniou, Antonis C. ;
Stoppa-Lyonnet, Dominique ;
Sinilnikova, Olga M. ;
Mazoyer, Sylvie .
HUMAN MUTATION, 2011, 32 (09) :1004-1007
[9]   Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response [J].
Gong, Wei-Jing ;
Yin, Ji-Ye ;
Li, Xiang-Ping ;
Fang, Chao ;
Xiao, Di ;
Zhang, Wei ;
Zhou, Hong-Hao ;
Li, Xi ;
Liu, Zhao-Qian .
TUMOR BIOLOGY, 2016, 37 (06) :8349-8358
[10]   miRNA interplay: mechanisms and consequences in cancer [J].
Hill, Meredith ;
Tran, Nham .
DISEASE MODELS & MECHANISMS, 2021, 14 (04)